Buy or sell Navigenics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Acquired

Navigenics Stock

Personal genomics

About Navigenics Stock

Navigenics, Inc. helps educate and empower individuals and their physicians with knowledge of their genetic predispositions, and then motivates them to act on the information to prevent the onset of disease, achieve earlier diagnosis, appropriately manage disease, or otherwise lessen its impact. Navigenics' lead investors are Kleiner Perkins Caufield and Byers, Sequoia Capital and MDV-Mohr Davidow Ventures.

Funding History

November 2007$25.0M
February 2010$18.0M

Management

Co-Founder

David B. Agus

Co-Founder, Chief Science officer

Dietrich Stephan

CEO

Vance Vanier

CFO

Matthew Garrett

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Navigenics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo